Baseline blood volume identified by dynamic contrast-enhanced computed tomography as a new independent prognostic factor in metastatic renal cell carcinoma()

BACKGROUND: Preliminary data showed prognostic impact of contrast-enhanced computed tomography (DCE-CT) identified Blood Volume (BV) in patients with metastatic renal cell carcinoma (mRCC). BV as an independent prognostic factor remains to be assessed. MATERIALS AND METHODS: DCE-CT identified BV was...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Transl Oncol
Autores principales: Drljevic-Nielsen, Aska, Rasmussen, Finn, Mains, Jill R., Thorup, Kennet, Donskov, Frede
Formato: Artigo
Lenguaje:Inglês
Publicado: Neoplasia Press 2020
Materias:
Original article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7350156/
https://ncbi.nlm.nih.gov/pubmed/32653813
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2020.100829
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares